BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38645356)

  • 1. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients.
    Alavanda C; Dirimtekin E; Mortoglou M; Arslan Ates E; Guney AI; Uysal-Onganer P
    ACS Omega; 2024 Apr; 9(15):17217-17228. PubMed ID: 38645356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.
    Erturk E; Cecener G; Tezcan G; Egeli U; Tunca B; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2015 Feb; 556(2):163-9. PubMed ID: 25445393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
    Ellakwa DE; Mushtaq N; Khan S; Jabbar A; Abdelmalek MA; Wadan AS; Ellakwa TE; Raza A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38619588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis.
    Tiberio P; Gaudio M; Belloni S; Pindilli S; Benvenuti C; Jacobs F; Saltalamacchia G; Zambelli A; Santoro A; De Sanctis R
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey.
    Boga I; Ozemri Sag S; Duman N; Ozdemir SY; Ergoren MC; Dalci K; Mujde C; Parsak CK; Rencuzogullari C; Sonmezler O; Yalav O; Alemdar A; Aliyeva L; Bozkurt O; Cetintas S; Cubukcu E; Deligonul A; Dogan B; Ornek Erguzeloglu C; Evrensel T; Gokgoz S; Senol K; Tolunay S; Akyurek E; Basgoz N; Gökçe N; Dundar B; Ozturk F; Taskin D; Demirtas M; Cag M; Diker O; Olgun P; Tug Bozdogan S; Dundar M; Bisgin A; Temel SG
    Eur J Breast Health; 2023 Jul; 19(3):235-252. PubMed ID: 37415649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer.
    Ruiz-Manriquez LM; Villarreal-Garza C; Benavides-Aguilar JA; Torres-Copado A; Isidoro-Sánchez J; Estrada-Meza C; Arvizu-Espinosa MG; Paul S; Cuevas-Diaz Duran R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
    Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
    Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the pathological classification of breast cancer.
    Rakha EA; Tse GM; Quinn CM
    Histopathology; 2023 Jan; 82(1):5-16. PubMed ID: 36482272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Regulatory Network Analysis Using miRNet 2.0.
    Chang L; Xia J
    Methods Mol Biol; 2023; 2594():185-204. PubMed ID: 36264497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future burden of breast cancer: Global statistics for 2020 and 2040.
    Arnold M; Morgan E; Rumgay H; Mafra A; Singh D; Laversanne M; Vignat J; Gralow JR; Cardoso F; Siesling S; Soerjomataram I
    Breast; 2022 Dec; 66():15-23. PubMed ID: 36084384
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.